GlassScriptPhysician profile
Katelyn Schutte
NPI 1396362729
$8,842.89
in general payments reported to CMS, 2019-2025
44 companies · $2,444 in 2025
The $2,444 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,701 · 2023: $1,961 · 2024: $2,736 · 2025: $2,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,140 · Education: $1.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,140.27 |
| Education | $1.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,131.32 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $1,110.06 | 2022-2025 | |
| Pfizer INC. | $862.08 | 2023-2025 | |
| Novo Nordisk INC | $790.34 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $666.93 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $571.93 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $504.85 | 2022-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Otsuka America Pharmaceutical, INC. | $317.59 | 2022-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Bayer Healthcare Pharmaceuticals INC. | $257.50 | 2022-2025 | |
| Amgen INC. | $250.06 | 2022-2025 | Evenity, Repatha, Otezla |
| Exact Sciences Corporation | $224.72 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $215.58 | 2022-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Astellas Pharma US INC | $165.71 | 2022-2025 | Veozah |
| Dexcom, INC. | $143.87 | 2022-2025 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $139.02 | 2022-2025 | Austedo Xr, Austedo Xr, Ajovy |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $128.75 | 2022-2025 | Trintellix |
| Novartis Pharmaceuticals Corporation | $127.98 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $117.12 | 2024 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $91.84 | 2024-2025 | Eliquis |
| Sumitomo Pharma America, INC. | $89.24 | 2024-2025 | Gemtesa |
| Lundbeck LLC | $86.08 | 2023-2024 | Rexulti |
| Axsome Therapeutics, INC. | $81.88 | 2023-2025 | Auvelity |
| Kowa Pharmaceuticals America, INC. | $76.83 | 2022-2024 | Livalo, Seglentis, Zoryve |
| Biohaven Pharmaceutical Holding Company LTD. | $70.80 | 2022 | |
| Organon LLC | $65.87 | 2024-2025 | Nexplanon, Nuvaring |
| Janssen Pharmaceuticals, INC | $60.30 | 2022-2025 | Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $50.44 | 2025 | Caplyta |
| Aimmune Therapeutics, INC. | $45.03 | 2024-2025 | Zenpep |
| Seqirus USA INC | $41.45 | 2023-2024 | Flucelvax Quadrivalent, Fluad Quadrivalent, Fluad |
| Paratek Pharmaceuticals, INC. | $36.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $31.20 | 2024 | |
| Eisai INC. | $30.47 | 2025 | |
| Currax Pharmaceuticals LLC | $29.59 | 2023-2025 | Contrave |
| Inari Medical, INC. | $27.94 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Esperion Therapeutics, INC. | $27.26 | 2024 | Nexletol |
| Vanda Pharmaceuticals INC. | $24.52 | 2022 | |
| Inspire Medical Systems, INC. | $23.65 | 2025 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.07 | 2023 | Xifaxan |
| Halozyme INC | $20.75 | 2023 | |
| Idorsia Pharmaceuticals US INC | $20.33 | 2023 | Quviviq |
| Pharmacosmos Therapeutics INC. | $20.00 | 2024 | Monoferric |
| Cranial Technologies, INC | $15.29 | 2025 | Doc Band |
| Phathom Pharmaceuticals, INC. | $14.92 | 2024 | Voquezna |
| Antares Pharma, INC. | $14.58 | 2023 | Nocdurna, Tlando, Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Schutte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.